Respiratory
System Cancers
Treatment for cancer, traditionally dominated by
cytotoxic and hormonal therapies, is currently
being revolutionized by the emergence of
innovative, targeted therapies with the
potential to offer improved efficacy and reduced
toxicity. One such class of innovative agents is
the epidermal growth factor receptor (EGFR)
inhibitor class, which is being investigated for
NSCLC and colorectal cancer.
Cancer that
forms in tissues of the lung, usually in the
cells lining air passages. The two main types
are small cell lung cancer and non-small cell
lung cancer. These types are diagnosed based on
how the cells look under a microscope.
Estimated new cases and deaths
from lung cancer (non-small cell and small cell
combined) in the United States in 2007:
|
 |
New cases: 213,380
|
| |
|
|
Deaths: 160,390 |
Respiratory Cancer
Products RC-DTX-06® and RC-PTX-06®
Locally Advanced or Metastatic Non–Small-Cell
Lung Cancer after failure of platinum-based
chemotherapy (second line)
Unresectable, Locally Advanced or Metastatic
Non-Small-Cell-Lung Cancer who have not
previously received chemotherapy for this
condition (first-line)
